Want to create an interactive transcript for this episode?
Podcast: Staying Connected
Episode: The DiSCOVER Trial: Part 2
Description: Part 2 of a two-part interview featuring Chris Schelling, CEO and Founder of Acer Therapeutics, and Dr. Adrian Quartel, Chief Medical Officer of Acer Therapeutics. In this episode, Adrian joins to discuss the details of the DiSCOVER trial, a clinical trial for Edsivo enrolling people with VEDSÂ (Vascular Ehlers-Danlos Syndrome) in the United States.Â
Learn more about the DiSCOVER Trial at discoverceliprolol.comÂ
Find more information about VEDS, including support groups and medical webinars, at https://TheVEDSMovement.org.Â
If you would like to share your story with VEDS on this podcast, visitÂ
https...